Authorities in South Korea have confirmed that the country will begin giving out fourth doses of COVID-19 vaccines by the end of February 2022, Reuters news agency reported on Monday.
Health Minister Kwon Deok-cheol told a COVID-19 response meeting that high-risk groups will be the first to get the fourth dose, or a second booster shot.
According to transcript of the meeting, Kwon said: "We're planning to provide fourth shots to those who live in nursing homes and care facilities and others with declined immunisation, in light of a recent increase of infections among people aged 60 or older."
Reportedly, at least 44.22 million people, or 86.2 percent of the population of South Korea, are considered fully vaccinated.
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses